Poly Historical Income Statement

POLYMED Stock

2,783 43.70 1.60%

Historical analysis of Poly Medicure income statement accounts such as Gross Profit of 9.3 B, Other Operating Expenses of 4.1 B, Operating Income of 6.5 B or Ebit of 3.7 B can show how well Poly Medicure Limited performed in making a profits. Evaluating Poly Medicure income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Poly Medicure's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Poly Medicure Limited latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Poly Medicure Limited is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Poly Medicure Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Poly Income Statement Analysis

Poly Medicure Limited Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Poly Medicure shareholders. The income statement also shows Poly investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Poly Medicure Income Statement Chart

At present, Poly Medicure's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 14.4 B, whereas Other Operating Expenses is forecasted to decline to about 4.1 B.

Selling General Administrative Total Revenue Gross Profit

Total Revenue

Total revenue comprises all receipts Poly Medicure Limited generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Poly Medicure Limited minus its cost of goods sold. It is profit before Poly Medicure operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Poly Medicure's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Poly Medicure Limited current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Poly Medicure Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2021	2022	2023	2024 (projected)
Interest Expense	37.2M	88.4M	130.5M	83.2M
Depreciation And Amortization	538.7M	571.2M	639.3M	671.2M

Interest Expense Depreciation And Amortization

Poly Medicure income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Selling And Marketing Expenses	Net Income From Continuing Ops	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.38	0.67	0.98	0.95	0.85	0.81	0.95	0.97	0.99	0.77	0.95	-0.83	0.95	0.95	0.9	0.03	0.92	0.88	0.77	-0.63	0.93
Interest Expense	0.38		0.25	0.35	0.36	0.38	0.3	0.33	0.34	0.34	0.34	0.31	-0.02	0.3	0.32	0.35	0.12	0.24	0.32	0.15	-0.83	0.25
Selling General Administrative	0.67	0.25		0.79	0.82	0.28	0.97	0.84	0.82	0.69	0.13	0.84	-0.67	0.84	0.84	0.42	-0.65	0.86	0.67	0.75	-0.51	0.64
Total Revenue	0.98	0.35	0.79		0.99	0.78	0.9	0.99	1.0	0.98	0.7	0.99	-0.87	0.99	0.99	0.85	-0.12	0.97	0.88	0.84	-0.61	0.92
Gross Profit	0.95	0.36	0.82	0.99		0.74	0.93	0.99	0.99	0.95	0.66	0.99	-0.87	0.99	0.99	0.8	-0.18	0.98	0.88	0.86	-0.62	0.91
Other Operating Expenses	0.85	0.38	0.28	0.78	0.74		0.47	0.72	0.74	0.83	0.96	0.72	-0.69	0.72	0.71	0.97	0.42	0.67	0.84	0.57	-0.45	0.86
Operating Income	0.81	0.3	0.97	0.9	0.93	0.47		0.94	0.93	0.83	0.34	0.94	-0.79	0.94	0.94	0.59	-0.5	0.95	0.78	0.83	-0.57	0.78
Ebit	0.95	0.33	0.84	0.99	0.99	0.72	0.94		1.0	0.96	0.62	1.0	-0.88	1.0	1.0	0.8	-0.21	0.99	0.88	0.86	-0.6	0.91
Ebitda	0.97	0.34	0.82	1.0	0.99	0.74	0.93	1.0		0.97	0.65	1.0	-0.88	1.0	1.0	0.82	-0.18	0.98	0.88	0.85	-0.61	0.92
Cost Of Revenue	0.99	0.34	0.69	0.98	0.95	0.83	0.83	0.96	0.97		0.74	0.96	-0.85	0.96	0.96	0.91	0.0	0.92	0.87	0.76	-0.57	0.92
Total Operating Expenses	0.77	0.34	0.13	0.7	0.66	0.96	0.34	0.62	0.65	0.74		0.62	-0.62	0.62	0.61	0.87	0.56	0.57	0.71	0.52	-0.41	0.77
Income Before Tax	0.95	0.31	0.84	0.99	0.99	0.72	0.94	1.0	1.0	0.96	0.62		-0.89	1.0	1.0	0.8	-0.22	0.99	0.88	0.85	-0.59	0.91
Total Other Income Expense Net	-0.83	-0.02	-0.67	-0.87	-0.87	-0.69	-0.79	-0.88	-0.88	-0.85	-0.62	-0.89		-0.9	-0.87	-0.76	0.17	-0.9	-0.82	-0.75	0.28	-0.88
Net Income	0.95	0.3	0.84	0.99	0.99	0.72	0.94	1.0	1.0	0.96	0.62	1.0	-0.9		0.99	0.8	-0.22	0.99	0.88	0.85	-0.59	0.91
Income Tax Expense	0.95	0.32	0.84	0.99	0.99	0.71	0.94	1.0	1.0	0.96	0.61	1.0	-0.87	0.99		0.8	-0.21	0.98	0.88	0.85	-0.58	0.9
Research Development	0.9	0.35	0.42	0.85	0.8	0.97	0.59	0.8	0.82	0.91	0.87	0.8	-0.76	0.8	0.8		0.28	0.75	0.87	0.61	-0.45	0.89
Selling And Marketing Expenses	0.03	0.12	-0.65	-0.12	-0.18	0.42	-0.5	-0.21	-0.18	0.0	0.56	-0.22	0.17	-0.22	-0.21	0.28		-0.3	-0.1	-0.2	0.07	-0.04
Net Income From Continuing Ops	0.92	0.24	0.86	0.97	0.98	0.67	0.95	0.99	0.98	0.92	0.57	0.99	-0.9	0.99	0.98	0.75	-0.3		0.88	0.85	-0.57	0.91
Tax Provision	0.88	0.32	0.67	0.88	0.88	0.84	0.78	0.88	0.88	0.87	0.71	0.88	-0.82	0.88	0.88	0.87	-0.1	0.88		0.76	-0.5	0.96
Interest Income	0.77	0.15	0.75	0.84	0.86	0.57	0.83	0.86	0.85	0.76	0.52	0.85	-0.75	0.85	0.85	0.61	-0.2	0.85	0.76		-0.46	0.72
Net Interest Income	-0.63	-0.83	-0.51	-0.61	-0.62	-0.45	-0.57	-0.6	-0.61	-0.57	-0.41	-0.59	0.28	-0.59	-0.58	-0.45	0.07	-0.57	-0.5	-0.46		-0.5
Reconciled Depreciation	0.93	0.25	0.64	0.92	0.91	0.86	0.78	0.91	0.92	0.92	0.77	0.91	-0.88	0.91	0.9	0.89	-0.04	0.91	0.96	0.72	-0.5

Click cells to compare fundamentals

Poly Medicure Account Relationship Matchups

Poly Medicure income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	404.7M	474.4M	538.7M	571.2M	639.3M	671.2M
Interest Expense	180.0M	77.4M	37.2M	88.4M	130.5M	83.2M
Selling General Administrative	171.8M	168.3M	171.6M	175.7M	2.5B	2.6B
Total Revenue	6.7B	7.8B	9.2B	11.2B	13.8B	14.4B
Gross Profit	3.8B	4.4B	4.8B	7.1B	8.9B	9.3B
Other Operating Expenses	5.4B	6.0B	7.5B	9.1B	7.6B	4.1B
Operating Income	1.2B	1.7B	1.6B	2.1B	6.2B	6.5B
Ebit	1.4B	1.9B	2.0B	2.4B	3.5B	3.7B
Ebitda	1.8B	2.3B	2.5B	3.0B	4.2B	4.4B
Cost Of Revenue	2.9B	3.4B	4.3B	4.1B	4.9B	5.1B
Total Operating Expenses	2.6B	2.7B	3.2B	5.0B	2.7B	1.8B
Income Before Tax	1.3B	1.8B	2.0B	2.4B	3.4B	3.6B
Total Other Income Expense Net	(13.7M)	(1.8B)	(1.9B)	(2.4B)	(2.7B)	(2.6B)
Net Income	958.8M	1.4B	1.5B	1.8B	2.6B	2.7B
Income Tax Expense	298.5M	441.8M	487.4M	582.1M	860.1M	903.1M
Research Development	119.4M	131.4M	187.7M	178.0M	189.6M	118.1M
Selling And Marketing Expenses	147.2M	126.3M	150.8M	205.1M	33.9M	32.2M
Net Income From Continuing Ops	958.8M	1.4B	1.5B	1.8B	2.6B	2.7B
Net Income Applicable To Common Shares	958.8M	1.4B	1.5B	1.8B	2.1B	2.2B
Tax Provision	298.5M	441.8M	487.4M	582.1M	860.1M	446.7M
Interest Income	4.6M	52.0M	18.1M	69.1M	79.5M	83.5M
Net Interest Income	(156.0M)	(85.1M)	(42.5M)	(88.4M)	(113.0M)	(118.7M)
Reconciled Depreciation	405.3M	475.2M	539.5M	571.7M	639.3M	518.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Poly Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Poly Historical Income Statement

About Poly Income Statement Analysis

Poly Medicure Income Statement Chart

Total Revenue

Gross Profit

Poly Medicure income statement Correlations

Poly Medicure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Poly Medicure income statement Accounts

Also Currently Popular

Other Information on Investing in Poly Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 1.0	Total Revenue
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Net Income	+ 1.0	Ebit
Income Tax Expense	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda

Net Income From Continuing Ops	- 0.9	Total Other Income Expense Net
Net Income	- 0.9	Total Other Income Expense Net
Total Other Income Expense Net	- 0.89	Income Before Tax
Reconciled Depreciation	- 0.88	Total Other Income Expense Net
Total Other Income Expense Net	- 0.88	Ebitda
Total Other Income Expense Net	- 0.88	Ebit